Immuneering Corp Share Price Today: Live Updates & Key Insights
Immuneering Corp share price today is $5.04, up 3.29%. The stock opened at $4.86 against the previous close of $4.86, with an intraday high of $5.03 and low of $4.76.
Immuneering Corp Share Price Chart
Immuneering Corp
Immuneering Corp Share Price Performance
Immuneering Corp Institutional Holdings
Immuneering Corp Market Status
Immuneering Corp Fundamentals
Market Cap 324.56 M
PB Ratio 1.4796
PE Ratio 0.0
Enterprise Value 154.26 M
Total Assets 231.99 M
Volume 7292770
Immuneering Corp Company Financials
About Immuneering Corp & investment objective
Company Information Immuneering Corporation, a late-stage oncology company, develops medicines for broad populations of cancer patients in the United States. The company develops IMM-1-104 (atebimetinib), a dual-MEK inhibitor that is in a Phase 3 clinical trial to treat patients with cancer, including pancreatic and non-small cell lung cancer caused by mutations of RAS or RAF; IMM-6-415 (envometinib), which is in Phase 1/2a clinical trial for the treatment of patients with solid tumors; and multiple deep cyclic inhibitor discovery programs. The company has clinical supply agreements with Regeneron Pharmaceuticals to evaluate atebimetinib in combination with Libtayo in patients with unresectable or metastatic RAS-mutant non-small cell lung cancer; and with Eli Lilly and Company to evaluate atebimetinib in combination with olomorasib in patients with advanced or metastatic KRAS G12C-mutant non-small cell lung cancer. Immuneering Corporation was incorporated in 2008 and is headquartered in Cambridge, Massachusetts.
Organisation Biotechnology
Employees 53
Industry Biotechnology
CEO Dr. Benjamin J. Zeskind M.B.A., Ph.D.
Trading and brokerage services provided by
Technology Services provided by Motilal Oswal Financial Services:
Disclaimer: These services are not for exchange traded products. The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Motilal Oswal Financial Services acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*
Take your next step
Immuneering Corp FAQs
What is the share price of Immuneering Corp today?
The current share price of Immuneering Corp is $5.04.
Can I buy Immuneering Corp shares in India?
Yes, Indian investors can buy Immuneering Corp shares by opening an international trading and demat account with Motilal Oswal.
How to buy Immuneering Corp shares in India?
You can easily invest in Immuneering Corp shares from India by:
- Direct Investment:
Opening an international trading account with Motilal Oswal which includes KYC verification in the US. Your account gets activated in a few minutes to a few hours, after which you can start adding funds in USD balance to buy Immuneering Corp shares. - Indirect Investment:
Under this form of investment, you can choose either a Mutual Fund (MF) or an Exchange-Traded Fund (ETF) that invests in global shares and start investing in shares of Immuneering Corp.
Can I buy fractional shares of Immuneering Corp?
Yes, many platforms allow you to buy fractional shares starting from as low as $1.
What is the market capitalization value of Immuneering Corp?
Immuneering Corp has a market cap of $324.56 M.
In which sector does Immuneering Corp belong?
Immuneering Corp operates in the Biotechnology sector.
What documents are required to invest in Immuneering Corp stocks?
To invest, you typically need:
What is the PE and PB ratio of Immuneering Corp?
The PE ratio of Immuneering Corp is N/A and the PB ratio is 1.48.